Starting with FDA approval of Donga super antibiotic, the birth of global drugs is expected to be in earnest

Starting with FDA approval of Donga super antibiotic, the birth of global drugs is expected to be in earnest.

On June 23, according to industry sources, it was identified that Green Cross and LG Life Sciences smoothly finished phase III clinical trials of global new drug, and are stepping on stage of the U.S. FDA approval process.

First, Green Cross finished phase III clinical trial of IVIG-S...